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sion became uniformly increased in hypertrophic chondrocytes,
whereas CD36 expression developed most robustly at sites of
the most intense injury. We demonstrated that forced expres-
sion of CD36 blocked the capacity of S100A11, TNFalpha and
CXCL8 to induced chondrocyte hypertrophy. CD36 also blocked
the capacity of S100A11 to inhibit proteoglycans synthesis. Last,
the PPARgamma agonist N-(2-Benzoylphenyl)-O-[2-(methyl-2-
pyridinylamino)ethyl]-L-tyrosine hydrate induced CD36 expres-
sion without affecting RAGE expression in chondrocytes.
Conclusions: Early induction of CD36 expression by chon-
drocytes occurs at sites of cartilage injury as OA develops
experimentally. PPARgamma ligation, which is chondroprotec-
tive, induces chondrocyte CD36 expression in vitro. Chondrocyte
CD36 expression suppresses the capacity of not only its ligand
S100A11, but also of TNFalpha and CXCL8 to induce chon-
drocyte hypertrophy, and CD36 expression promotes preserva-
tion of proteoglycans synthesis. We conclude that chondrocyte
expression of CD36 is chondroprotective by disengaging re-
sponsiveness to inﬂammation from dysregulated chondrocyte
differentiation and function.
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THE “ALARMIN” S100 A8: AN ACTIVATOR OF
CHONDROCYTE MEDIATED CARTILAGE DAMAGE?
P. van Lent1, L. Grevers1, A. Blom1, A. Sloetjes1, T. Vogl2,
W. Nacken2, J. Roth2, W. van den Berg1
1Radboud University Medical Centre, Nijmegen, The
Netherlands; 2Inst of Experimental Dermatology, Muenster,
Germany
Purpose: In a previous study we have shown that “alarmins”
S100A8 and S100A9 which can form dimers and are predomi-
nantly produced by myeloid cells in the synovial ﬂuid and synovial
membrane are involved in MMP-mediated cartilage destruction
during experimental arthritis. S100A8 forms the active part which
is stabilized by S100A9 and protects S100A8 from degradation.
As MMP mediated cartilage destruction is particularly found
around the chondrocyte this prompted us to investigate whether
S100A8 and A9 are produced by chondrocytes and whether
these “alarmins” are actively involved in MMP-mediated chon-
drocyte activation.
Methods: S100A8 and A9 proteins were detected in knee
joints of murine arthritis and osteoarthritis using immunolocal-
isation. Murine chondrocyte cell line H4 was stimulated with
pro-inﬂammatory cytokines (100 ng/ml) to investigate rS100A8
and A9 production or by recombinant S100A8 (0.2, 1 and 5
µg/ml) to investigate MMP and cytokine production.mRNA and
protein levels were measured using RT-PCR and blotanalysis.
S100A8/A9 dimers and cytokines were measured in culture su-
pernatant using ELISA and Luminex. Breakdown of aggrecan on
the pericellular surface of the chondrocyte was measured us-
ing VDIPEN and NITEGE (MMP and aggrecanase neoepitopes)
antibodies and FACS analysis.
Results: Immunolocalisation of inﬂamed knee joints depicted
that S100A8 and S100A9 proteins were abundantly expressed in
chondrocytes. Expression was particularly found in the superﬁcial
layers of the cartilage surfaces at the margins of the joint. Stim-
ulation of murine chondrocytes by pro-inﬂammatory cytokines
IL-17, IL-18 and IFNγ caused strong upregulation of particularly
S100A8 and in lesser extent S100A9 mRNA (S100A8: 24, 48
and 4 fold and S100A9: 4, 4 and 0 fold respectively). Stimulation
of chondrocytes by rS100A8 caused a signiﬁcant autoinduction
of S100A8 and in lesser extend upregulation of S100A9 mRNA
and protein levels. High concentrations of cytokines IL-6, KC and
RANTES were measured in the culture supernatant whereas
TNFα, IL-1α and β were below detection level. S100A8/A9 dimers
could not be detected by ELISA conﬁrming that S100A8 is the
active component and can directly activate chondrocytes. More-
over MMPs (-2,-3,-9,-13) and ADAMTS(-4,-5) mRNA levels in
the chondrocyte were strongly upregulated (maximal at 1 µg/ml
(4, 4, 3, 16, 8 and 4 times respectively). VDIPEN and NITEGE
neoepitopes on the pericellular membrane of chondrocytes were
signiﬁcantly elevated after stimulation with rS100A8 for 24 hours
in a concentration (0,2, 1 and 5 µg/ml) dependent manner.
(VDIPEN 17,67,108% and NITEGE 8, 33 and 67% respectively).
Conclusions: The alarmin S100A8 is produced by chondro-
cytes and directly activates MMP and aggrecanase mediated
peri-cellular matrix degradation. S100A8 may be an important
mediator of severe cartilage destruction.
41
INTERLUKIN-7 STIMULATES SECRETION OF S100A4 BY
ACTIVATING THE JAK-STAT PATHWAY IN HUMAN
ARTICULAR CHONDROCYTES
R.R. Yammani, D. Long, R. Loeser
Wake Forest University School of Medicine, Winston-Salem, NC
Purpose: S100A4, a member of the S100 family of calcium bind-
ing proteins, has been shown to be increased in OA cartilage and
to stimulate chondrocyte RAGE signaling resulting in increased
expression of MMP-13. Members of S100 family are known to be
secreted into the extra-cellular environment, however the mech-
anism(s) of secretion is not completely understood. The aim of
this study was to determine the pathway involved in secretion of
S100A4 in response to cytokines in chondrocytes.
Methods: Human articular chondrocytes isolated from normal
ankle cartilage obtained from tissue donors were cultured in
high density monolayers in media with 10% serum for 5-7 days.
Conﬂuent monolayers were then changed to serum free media
16-18hr prior to treatment with 10ng/ml of IL-7, IL-1β and TNF
α. In some experiments, cells were pre-treated with a JAK-3
inhibitor or Brefeldin-A (BFA), a chemical inhibitor that blocks
classical protein translocation. Immuno-blotting with phospho-
speciﬁc antibodies was used to determine the activation of
signaling proteins. Secretion of S100A4 was measured in the
conditioned media by immuno-blotting with polyclonal antibodies
to S100A4.
Results: Chondrocyte secretion of S100A4 was observed af-
ter treatment with IL-7 and TNFα but not with IL-1β. Treatment
with IL-7 resulted in activation of the JAK/STAT pathway with
increased phosphorylation of JAK-3 and STAT-3. IL-7 stimulation
of S100A4 secretion was inhibited by pretreatment with a JAK-3
inhibitor. In addition, pretreatment with Brefeldin-A (BFA) didn’t
effect the secretion of S100A4 suggesting a pathway indepen-
dent of Golgi-endoplasmic reticulum (classical pathway).
Conclusions: Our study demonstrates for the ﬁrst time that IL-7
or TNFα but not IL-1β can stimulate chondrocyte secretion of
S100A4 via activation of JAK/STAT signaling. We have recently
found that OA chondrocytes produce IL-7 and others have shown
TNFα. These cytokines may contribute to cartilage destruction
through secretion of S100A4 which can function as an autocrine
factor to stimulate MMP-13 production via RAGE.
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INFLAMMATORY GENE EXPRESSION IN EARLY KNEE
OSTEOARTHRITIS PATIENTS
C.R. Scanzello, S. Rodeo, R. Marx, T. Miles, E. Umoh,
M.K. Crow
Hospital for Special Surgery, New York, NY
Purpose: Synovial inﬂammation in osteoarthritis (OA) patients
has been associated with increased pain, disability, and more
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rapid disease progression. Indeed, many patients develop in-
ﬂammatory inﬁltrates containing macrophages and lymphocytes
within the synovial membrane. However, as most of what we
know about synovial inﬂammation in OA comes from studies of
end-stage disease, we set out to characterize inﬂammatory gene
expression within the synovial membrane (SM) of a well char-
acterized group of patients with early knee OA. The purpose of
this study was to quantify cytokine and cell-lineage speciﬁc tran-
scripts within the SM of patients with early knee OA as compared
to SM from patients with advanced OA.
Methods: SM specimens from patients with osteoarthritis were
collected at the time of total knee arthroplasty (end-stage OA,
n=13) or knee arthroscopy for degenerative meniscal tears (early
OA, n=18). Inclusion criteria for the early OA group was as fol-
lows: age > 40, knee pain > 3 months, cartilage abnormality
seen on preoperative MRI, and Kellgren-Lawrence grade of <
2 on pre-operative knee ﬁlms. Exclusions included patients with
a history of traumatic or sports-related knee injury, previous
surgery to the knee, intra-articular corticosteroid or hyaluronan
within the past 3 months, or a history of septic, inﬂammatory
or crystalline arthritis. RNA was extracted from SM specimens
after tissue homogenization using a commercially available pu-
riﬁcation kit (Gentra Systems, Inc. VersageneTM RNA Tissue
kit). cDNA was synthesized from < 1 ug of total RNA. Relative
expression levels (normalized to GAPDH) of cell-lineage speciﬁc
transcripts (CD3delta, CD4, CD8, CD68, CD38) and cytokines
(IL-1beta, TNF-alpha, IL-15, IL-6, IL-10 and TGF-beta1) were
determined using quantitative real-time PCR analysis. Relative
expression levels of transcripts were compared in early and
end-stage specimens, using the Mann-Whitney t-test.
Results: Most cell-lineage speciﬁc transcripts levels were similar
in early and advanced disease, with the exception of CD38, a
plasma cell marker, which was higher in the advanced patients
(median, interquartile range: 8.11, 6.46-19.38) compared with
the early patients (1.18, 0.5-1.63, p=0.0002). Expression levels
of IL-15 were signiﬁcantly higher in early OA synovial specimens
(22.71, 12-25.97) compared with advanced OA specimens (6.87,
2.9-13.7, p=0.004).
Conclusions: In this well-characterized group of early knee OA
patients, there was evidence of a synovial inﬂammatory compo-
nent at the level of gene transcription which was comparable to
that seen in end-stage disease. Further studies on this group
of patients may conﬁrm a role for distinct cytokines and provide
insight into inﬂammatory mechanisms at the early stage of joint
degeneration.
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GENDER AND ARTHROPLASTY TYPE AFFECTS THE
PREVALENCE OF MODERATE OR SEVERE PAIN POST
TOTAL HIP ARTHROPLASTY (THA)
J.A. Singh1, S. Gabriel2, D. Lewallen2
1Minneapolis VA Medical Center, Minneapolis, MN; 2Mayo Clinic
School of Medicine, Rochester, MN
Purpose: To investigate the impact of age, gender and Arthro-
plasty type (primary vs. revision) on prevalence of moderate or
severe hip pain.
Methods: Using an Institutional Total Joint Registry, we identiﬁed
a cohort of patients who underwent primary of revision THA
from 1996-2004 and responded to the follow-up questionnaires.
We compared the prevalence of moderate or severe hip pain
based on type of arthroplasty (primary vs. revision THA), gender
(female vs. male) and by age. Results based on gender and
type of arthroplasty were analyzed by comparing proportions
and based on age by using Chi-square tests, considering a
p-value<0.05 signiﬁcant.
Results: We reviewed 1,526 primary THA patients at 1-year
and 4,415 at 2-years comparing men to women (733 M, 816
F at 1-year; 2,199 M, 2,317 F at 2-years), stratiﬁed by age.
642 revision THA patients at 1-year and 2,038 at 2-years were
similarly studied (289 M, 353 F at 1-year; and 947 M, 1,091 F at
2-years). Moderate or severe pain was less prevalent following
primary vs. revision THA at 1-year (5.5% vs. 9.8%, p<0.001),
and 2-years post-surgery (7.5% vs. 16.3% vs.; p<0.001).
Comparing women and men, the prevalence of moderate or
severe pain at 1-year post-arthroplasty was similar for both
primary THA and revision THA: 6.3% vs. 4.6%, p=0.13; and
11.8% vs. 7.3%, p=0.058, respectively; and in revision THA at
2-years: 17.7% vs. 14.7%, p=0.068. However at 2-years, a higher
percentage of women than men had moderate or severe pain in
primary THA group: 8.8% vs. 6.6%, p=0.042; respectively.
Age had a signiﬁcant impact on prevalence of moderate or severe
pain after 1- and 2-years after primary THA with lower prevalence
of pain in 61-70 yr age group compared to other age categories
(p=0.01 and p<0.001), but did not have a signiﬁcant impact on
prevalence of moderate or severe pain following revision THA
(p=0.406 and p=0.397, respectively).
Conclusions: Moderate or severe pain was no different by
gender at 1-year, but was more prevalent in women with primary
THA at 2-years. This might suggest that factors not directly
related to surgery play a role in these differences. Factors such
as bone remodeling, differences in recovery of strength and
endurance, activity level or comorbidities may be important and
candidates for further investigation. As expected, the long-term
pain outcomes of Primary THA are signiﬁcantly better than
those following revision THA. Interestingly, patients in 61-70 yr
age group had lower prevalence of moderate-severe pain post
primary THA but not post-revision THA. The reasons for this are
unclear, but may indicate the “most appropriate functional status
and lower pre-operative pain level for primary THA” for this
age group compared to either younger patients who might have
higher levels of activity or older patients who may have poorer
functional status and higher pain level pre-operatively. Factors
associated with these gender- and arthroplasty type-differences
deserve further study.
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PREDICTORS OF PROGRESSION TO TOTAL HIP
ARTHROPLASTY FOLLOWING ARTHROSCOPIC
DECOMPRESSION OF FEMOROACETABULAR
IMPINGEMENT
M.J. Philippon, D.A. Kuppersmith, Y-M. Yen, K.K. Briggs
Steadman Hawkins Research Foundation, Vail, CO
Purpose: The purpose of this study was to stratify variables that
may predict the progression to total hip arthoplasty (THA) follow-
ing arthroscopic intervention for femoroacetabular impingement.
We hypothesize that older patients with decreased joint space
would progress to total hip arthroplasty following arthroscopic
intervention.
Methods: Between March 2005 and March 2006, a cohort of
326 patients underwent arthroscopic treatment of femoroacetab-
ular impingement. Average age at time of surgery was 39 years
(range 16 to 77). Pre-operative AP-pelvic radiographs were used
to measure joint space of the weight bearing surface laterally,
mid, and at the fovea. Patient completed subjective question-
naires were ﬁlled out pre-operatively and at 1 year post-operative.
Outcome measures collected were the Modiﬁed Harris Hip Score
(MHHS), Non-arthritic hip score (NAHS), Hip outcome score
(HOS) activities of daily living (ADL) and sports sub scale, and
patient satisfaction.
Results: Preoperatively, increasing age correlated with de-
creased weight bearing joint space laterally (r = -0.269, p =
0.001), mid (r = -0.252, p = 0.001) and at the fovea (r = -0.301,
